Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)

Clinical trial NCT04823585 · COMPLETED

Trial details

NCT number: NCT04823585
Sponsor: Helsinki University Central Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Asthma, Aspirin-Induced Chronic Rhinosinusitis With Nasal Polyps

Start date: 2021-08-12
Primary completion: 2025-01-16
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.